JOANNE PATTERSON: Open Payments
NPI 1457516510 · FORT BRAGG, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 27 payments from 17 companies in 2025. Trend: 2023 $85 · 2024 $512 · 2025 $696
Food & beverage: $596Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $166 |
| Janssen Biotech, Inc. | 4 | $121 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Rigel Pharmaceuticals, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $22 |
Products named: Enhertu, KEYTRUDA, RYBREVANT, ERLEADA, TAVALISSE, Xtandi, ULTOMIRIS, TAGRISSO.
Industry payments across CA — which companies pay providers there.
